Valuation: BioElectronics Corporation

Market Cap 12.35M 10.7M 10.12M 9.16M 17.19M 1.18B 17.32M 121M 46.45M 601M 46.4M 45.37M 1.92B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 22.26M 21.05M 19.05M 35.76M 2.46B 36.03M 251M 96.62M 1.25B 96.52M 94.37M 3.99B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week+14.29%
Current month+48.15%
1 month+33.33%
3 months+14.29%
1 week 0
Extreme 0.0003
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member - 15/11/2019
Chairman 85 15/06/2020
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+14.29%+100.00%-.--% 8.65M
+4.61%+6.36%+35.18%+24.41% 227B
+3.01%+2.01%+11.04%-17.98% 143B
-0.21%+7.71%-13.09%+27.62% 134B
-2.62%-2.47%-56.07%-17.07% 65.29B
-0.31%+0.65%-18.37%-14.19% 50.09B
+0.26%-1.13%+12.74%+17.13% 49.29B
+2.36%+2.33%+19.61%+29.64% 41.39B
+1.73%+3.52%+39.48%+51.23% 40.28B
+2.89%+3.80%-15.40%+57.81% 31.9B
Average +1.27%-1.56%+11.51%+15.86% 78.15B
Weighted average by Cap. +2.21%-0.91%+7.38%+13.83%

Financials

2020 2021
Net sales 830K 719K 679K 615K 1.15M 79.58M 1.16M 8.11M 3.12M 40.35M 3.12M 3.05M 129M 1.61M 1.39M 1.32M 1.19M 2.24M 154M 2.26M 15.73M 6.05M 78.28M 6.05M 5.91M 250M
Net income -1.16M -1M -950K -860K -1.61M -111M -1.63M -11.34M -4.36M -56.41M -4.36M -4.26M -180M -290K -251K -237K -215K -403K -27.8M -406K -2.83M -1.09M -14.1M -1.09M -1.06M -44.96M
Net Debt 13.07M 11.32M 10.7M 9.69M 18.19M 1.25B 18.32M 128M 49.14M 636M 49.09M 48M 2.03B 13.34M 11.56M 10.93M 9.89M 18.57M 1.28B 18.71M 130M 50.17M 649M 50.12M 49M 2.07B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
14/09/26 $0.000350 -.--% 2,842,500
11/09/26 $0.000350 +16.67% 434,000
10/09/26 $0.000300 -.--% 3,036,501
09/09/26 $0.000300 -14.29% 2,970,000
  1. Stock Market
  2. Stocks
  3. BIEL Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!